Dogwood Therapeutics, Inc.
DWTX
$4.90
$0.102.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.99M | 5.23M | 1.77M | 733.70K | 970.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.43M | 7.54M | 2.30M | 1.07M | 1.31M |
| Operating Income | -4.43M | -7.54M | -2.30M | -1.07M | -1.31M |
| Income Before Tax | -10.73M | -7.73M | -2.28M | -1.05M | -1.29M |
| Income Tax Expenses | 190.50K | -500.00 | -- | -- | -- |
| Earnings from Continuing Operations | -10.93M | -7.73M | -2.28M | -1.05M | -1.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.93M | -7.73M | -2.28M | -1.05M | -1.29M |
| EBIT | -4.43M | -7.54M | -2.30M | -1.07M | -1.31M |
| EBITDA | -4.41M | -7.54M | -- | -- | -- |
| EPS Basic | -8.45 | -6.29 | -2.05 | -1.15 | -1.68 |
| Normalized Basic EPS | -1.99 | -3.69 | -1.28 | -0.72 | -1.05 |
| EPS Diluted | -8.45 | -6.29 | -2.05 | -1.15 | -1.68 |
| Normalized Diluted EPS | -1.99 | -3.69 | -1.28 | -0.72 | -1.05 |
| Average Basic Shares Outstanding | 1.44M | 1.31M | 1.11M | 916.00K | 770.30K |
| Average Diluted Shares Outstanding | 1.44M | 1.31M | 1.11M | 916.00K | 770.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |